Clinical Outcomes of Switching U-100 Intermediate or Basal Insulin to U-200 Insulin Degludec or U-300 Insulin Glargine
2025 · Journal of Primary Care & Community Health · 1 citations
https://doi.org/10.1177/21501319251327318
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
0
Papers
0
Citations
Cami Hunger is an academic researcher.
Click to start Chat